REGENEREX PHARMA, INC. - (RGPX)
10-K Filing Date: June 24, 2024
ITEM 1C. CYBERSECURITY.
The Company’s cyber risk management strategy has consisted of a focus on minimizing our attach surface and leveraging industry standard cyber threat prevention, detection, and remediation tools. The Company assesses cyber security risk as follows:
| • | We have executed on this strategy with a cloud-first approach, awareness training, and deliberate use of well-established vendors for software and hardware solutions. |
| • | The Company’s IT manager is engaging an independent service with its expertise specifically in cybersecurity and risk mitigation to review our IT as a risk service consultant. |
To date, no cybersecurity threats have materially affected our business strategy, operations, or financial condition.